STEVANATO GROUP S.P.A. revenue for the last year amounted to 20.35 B MXN, the most of which — 16.15 B MXN — came from its highest performing source at the moment, Biopharmaceutical and Diagnostic Solutions, the year earlier bringing 16.39 B MXN. The greatest contribution to the revenue figure was made by EMEA — last year it brought STEVANATO GROUP S.P.A. 11.64 B MXN, and the year before that — 12.29 B MXN.